Hualan Biological Bacterin Inc. Posted 94 Million Yuan Net Profit in First Quarter of 2023

Hualan Biological Bacterin Inc. (华兰生物疫苗股份有限公司) (301207.SZ) reported a net profit of 94 million yuan in the first quarter of 2023, reversing a net loss of 849,919 yuan for the same period in the previous year.

Meanwhile, the company posted 144.8 million yuan in revenue, up 893% year-on-year.

At the end of the reporting period, it had 7.1 billion yuan in total assets and 1.5 billion yuan in total liabilities, with a liability-to-asset ratio of 21.2%.